Moody’s revises Berkshire Health System’s outlook to negative

Moody’s Investors Service affirmed its “A3” rating Pittsfield, Mass.-based Berkshire Health System’s revenue bonds.

Advertisement

The affirmation is a result of several factors, including BHS’ strong market position, solid financial profile and modest debt burden. Moody’s acknowledged the health system’s weaker-than-expected margins in fiscal year 2017, upcoming EMR implementation and uncertainty of work stoppages as the nurses’ union strikes over a new contract.

The outlook was revised to negative from stable, reflecting Moody’s expectation that the health system’s margins will remain suppressed and under pressure over the next several years.

More articles on healthcare finance:
Donations to USC medical school fall 55% after dean, faculty scandals
U of Texas Health renames cancer center after donors of $25M gift
10 recent hospital, health system outlook and credit rating actions

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.